(Q34036808)

30 July 2017

Diagnostic value of controlled attenuation parameter for liver steatosis in patients with chronic hepatitis B (English)

1 reference

30 July 2017

1 reference

1 reference

1 reference

Chun-Yan Wang

1

1 reference

30 July 2017

Wei Lu

2

1 reference

30 July 2017

Dong-Sheng Hu

3

1 reference

30 July 2017

Guang-Dong Wang

4

1 reference

30 July 2017

Xiao-Jing Cheng

5

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 August 2014

1 reference

World Journal of Gastroenterology

30 July 2017

1 reference

30 July 2017

20

1 reference

30 July 2017

30

1 reference

30 July 2017

10585-10590

1 reference

The controlled attenuation parameter (CAP): a novel tool for the non-invasive evaluation of steatosis using Fibroscan

30 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4130870

Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4130870

Co-factors in liver disease: the role of HFE-related hereditary hemochromatosis and iron

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4130870

Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4130870

Steatosis: co-factor in other liver diseases.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4130870

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4130870

Alcoholic liver disease (ALD): a new domain for prevention efforts

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4130870

Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4130870

Guidelines on the use of liver biopsy in clinical practice

5 July 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4130870

5 July 2018

https://api.crossref.org/works/10.3748%2FWJG.V20.I30.10585

Controlled attenuation parameter (CAP): a novel VCTE™ guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.3748%2FWJG.V20.I30.10585

Sonographic hepatic-renal ratio as indicator of hepatic steatosis: comparison with (1)H magnetic resonance spectroscopy.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.3748%2FWJG.V20.I30.10585

Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.3748%2FWJG.V20.I30.10585

Prevalence of and risk factors for hepatic steatosis in Northern Italy

21 January 2018

1 reference

12 December 2020

Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography

1 reference

12 December 2020

Natural history of nonalcoholic steatohepatitis: a longitudinal study of repeat liver biopsies

1 reference

12 December 2020

Pathological diagnosis of chronic hepatitis C: a multicenter comparative study with chronic hepatitis B. The Hepatitis Interventional Therapy Group

1 reference

12 December 2020

Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis

1 reference

12 December 2020

Nonalcoholic Fatty Liver Disease in Severely Obese Subjects

1 reference

12 December 2020

Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan®: validation in chronic hepatitis C

1 reference

12 December 2020

Controlled attenuation parameter (CAP): a new device for fast evaluation of liver fat?

1 reference

12 December 2020

10.3748/WJG.V20.I30.10585

Identifiers

DOI

1 reference

30 July 2017

1 reference

30 July 2017

1 reference